Evidence‑based complementary and alternative medicine bioinformatics approach through network pharmacology and molecular docking to determine the molecular mechanisms of Erjing pill in Alzheimer's disease

Abstract

Erjing pill, a Traditional Chinese Medicine (TCM) formulation composed of Polygonatum sibiricum and Lycium chinense, has an important role in the treatment of Alzheimer's disease (AD). However, the underlying mechanisms of the action of Erjing pill in AD have remained elusive. In the present study, the key ingredients of Erjing pill were investigated and the active components and their mechanisms of action on AD were analyzed based on networks pharmacology. By using the TCM and TCM Systems Pharmacology and databases, the components of Erjing pill were screened and the data were captured using Discovery Studio. The SwissTarget webserver database was used to predict the potential protein targets of Erjing pill components for pathologies related to AD. The data were further analyzed with the disease targets of AD based on analysis of the Online Mendelian Inheritance in Man, DiGSeE and Therapeutic Target Database. Subsequent analysis of mechanistic pathways of the screened components and protein targets allowed us to construct a network by using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes, which revealed potential molecular mechanisms of Erjing pill against AD. Finally, the protective effect of three active components on neurons was verified using an in vitro injury model of PC12 cells induced by Aβ 25-35 . The results indicated that 65 bioactive components of Erjing pill, including lauric acid and zederone, and 6 targets, including acetylcholinesterase, butylcholinesterase and amyloid protein precursor, were closely associated with the prevention and treatment of AD. The molecular components of Erjing pill were indicated to be involved in various biological signaling processes, mainly in synaptic signal transmission, transsynaptic signal transmission and chemical synaptic transmission. Furthermore, related pathways targeted by Erjing pill in AD included the regulation of neuroactive ligand-receptor interactions, the PI3K-Akt signaling pathway, serotoninergic synapses, calcium signaling pathways and dopaminergic synapses. A cell viability assay indicated that the compounds (polygonatine A, polygonatine C and 4' ,5-dihydroxyflavone) assessed were able to significantly improve the survival rate and increase the Ca 2+ level in a PC12 cell model of AD induced by amyloid-β 25-35 . The present study revealed that the mechanisms of action of Erjing pill to prevent and treat AD included a multicompound, multitarget and multipathway regulatory network.

Network pharmacology and molecular docking integrated strategy to investigate the pharmacological mechanism of palmatine in Alzheimer's disease

“…Current drugs applied to AD with a single target can only delay the symptoms of AD to a certain extent and have more serious side effects. [ 32 ] Studies have shown that TNF‐α, IL‐6, and IL‐1β levels are significantly elevated in the serum and brain of AD patients and AD animal models. Increased pro‐inflammatory levels promote Aβ production and tau protein phosphorylation.…”

Long-term 25-hydroxy vitamin D level of patients supplied with total thyroidectomy due to nodular goiter

“…In some recent clinical studies, it has been claimed that there is no relationship between Ca level and 25-OH D3 level after total thyroidectomy. Singh et al [22] reported that preoperative 25-OH D3-vitamin level did not affect postoperative Ca level in patients who underwent total thyroidectomy. In the study conducted by Al-Khatib et al [23], it was reported that low 25-OH D3 level affects the early postoperative Ca level but not the longterm Ca level in patients who underwent total thyroidectomy.…”

An integrated approach of network pharmacology and molecular docking analyses for identification of Lepidium sativum L. antidiabetic molecular targets

“…Only compounds that complied with three or more of the aforementioned characteristics were maintained in the database. L. sativum constituents' oral bioavailability (OB) was also estimated (Yang et al, 2021). It shows how much of a drug dosage taken orally reaches the therapeutic site of action without change.…”